Dr. Kent Holtorf
Integrative Medicine Physician
MD with a clinical focus on integrative and regenerative medicine. Dr. Kent Holtorf co-founded Integrative Peptides LLC, which sells oral BPC-157 (500mcg capsules), and founded Holtorf Medical Group. His immune modulation protocol uses standard clinical doses of TA-1, BPC-157, and Epithalon. Transparency note: FTC warning letter for unsubstantiated COVID treatment claims, and a RAADFest 2024 safety incident where two patients were hospitalized after peptide injections at his booth.
Dr. Kent Holtorf is an MD specializing in integrative and regenerative medicine. He co-founded Integrative Peptides LLC, which sells oral BPC-157 (500mcg capsules), and founded Holtorf Medical Group. His immune modulation protocol uses standard clinical doses of TA-1 (1.6mg 2x/week), oral BPC-157 (250-500mcg 1-2x/day), and Epithalon (10mg daily for 10 days, every 6 months).
Transparency requires noting several conflicts. Holtorf Medical Group received an FTC warning letter for unsubstantiated COVID treatment claims involving peptides and colloidal silver. At RAADFest 2024, two patients were hospitalized (intubated) after peptide injections at his booth; both recovered, and Holtorf attributed the reactions to compounding agents. His oral BPC-157 recommendation (500mcg) matches the exact product Integrative Peptides sells.
One protocol is tracked on this page. The dosing is standard clinical range, but the commercial conflict is the highest of any creator on this platform. Evaluate accordingly.
Protocols by Dr.
1 disclosed protocol with verified dosing details.
Frequently Asked Questions
Not medical advice. Talk to your provider before using any peptide.
Full disclaimer